Incyte (INCY) Other Working Capital Changes (2010 - 2026)
Incyte posted quarterly Other Working Capital Changes of -$9.2 million for Q1 2026, down 114.82% year-on-year from $62.0 million in Q1 2025, and up 85.87% on a QoQ basis from -$65.0 million in Q4 2025.
Incyte (INCY) has 17 years of Other Working Capital Changes data on file, last reported at -$9.2 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 114.82% year-over-year to -$9.2 million; the trailing twelve-month figure through Mar 2026 stood at $85.0 million (up 70.06% YoY), and the FY2025 full-year result was $156.2 million, up 1607.35% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$9.2 million, up from -$65.0 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $86.4 million in Q2 2025 and bottomed at -$65.7 million in Q4 2024.
- The 5-year median for Other Working Capital Changes is $14.0 million (2022), against an average of $12.3 million.
- The widest annual swing landed in 2023, when Other Working Capital Changes tumbled 241.42%; it then jumped 3554.0% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at -$9.3 million in 2022, then slumped by 111.17% to -$19.6 million in 2023, then slumped by 235.61% to -$65.7 million in 2024, then advanced by 1.08% to -$65.0 million in 2025, then soared by 85.87% to -$9.2 million in 2026.
- The last three Other Working Capital Changes figures came in at -$9.2 million (Q1 2026), -$65.0 million (Q4 2025), and $72.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.19 Mn |
| Mar 31, 2026 | -9.19 Mn |
| Dec 31, 2025 | -65.04 Mn |
| Dec 31, 2025 | -65.04 Mn |
| Sep 30, 2025 | 72.84 Mn |
| Sep 30, 2025 | 72.84 Mn |
| Jun 30, 2025 | 86.40 Mn |
| Jun 30, 2025 | 86.40 Mn |
| Mar 31, 2025 | 62.05 Mn |
| Mar 31, 2025 | 62.05 Mn |
| Dec 31, 2024 | -65.75 Mn |
| Dec 31, 2024 | -65.75 Mn |
| Sep 30, 2024 | 15.63 Mn |
| Sep 30, 2024 | 15.63 Mn |
| Jun 30, 2024 | 38.05 Mn |
| Jun 30, 2024 | 38.05 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | -19.59 Mn |
| Dec 31, 2023 | -19.59 Mn |
| Sep 30, 2023 | 53.86 Mn |
| Sep 30, 2023 | 53.86 Mn |
| Jun 30, 2023 | -16.14 Mn |
| Jun 30, 2023 | -16.14 Mn |
| Mar 31, 2023 | 24.35 Mn |
| Mar 31, 2023 | 24.35 Mn |
| Dec 31, 2022 | -9.28 Mn |
| Dec 31, 2022 | -9.28 Mn |
| Sep 30, 2022 | 14.64 Mn |
| Sep 30, 2022 | 14.64 Mn |
| Jun 30, 2022 | 11.41 Mn |
| Jun 30, 2022 | 11.41 Mn |
| Mar 31, 2022 | 13.97 Mn |
| Mar 31, 2022 | 13.97 Mn |
| Dec 31, 2021 | 39.30 Mn |
| Dec 31, 2021 | 39.30 Mn |
| Sep 30, 2021 | 21.80 Mn |
| Sep 30, 2021 | 21.80 Mn |
| Jun 30, 2021 | -7.80 Mn |
| Jun 30, 2021 | -7.80 Mn |
| Mar 31, 2021 | 10.78 Mn |
| Mar 31, 2021 | 10.78 Mn |
| Dec 31, 2020 | -3.33 Mn |
| Dec 31, 2020 | -3.33 Mn |
| Sep 30, 2020 | -279,000.00 |
| Sep 30, 2020 | -279,000.00 |
| Jun 30, 2020 | -5.04 Mn |
| Jun 30, 2020 | -5.04 Mn |
| Mar 31, 2020 | 16.70 Mn |
| Mar 31, 2020 | 16.70 Mn |
| Dec 31, 2019 | 4.26 Mn |
| Dec 31, 2019 | 4.26 Mn |
| Sep 30, 2019 | -1.65 Mn |
| Sep 30, 2019 | -1.65 Mn |
| Jun 30, 2019 | -2.80 Mn |
| Jun 30, 2019 | -2.80 Mn |
| Mar 31, 2019 | -5.56 Mn |
| Mar 31, 2019 | -5.56 Mn |
| Dec 31, 2018 | 12.08 Mn |
| Dec 31, 2018 | 12.08 Mn |
| Sep 30, 2018 | -2.26 Mn |
| Sep 30, 2018 | -2.26 Mn |
| Jun 30, 2018 | 4.67 Mn |
| Jun 30, 2018 | 4.67 Mn |
| Mar 31, 2018 | 18.92 Mn |
| Mar 31, 2018 | 18.92 Mn |
| Dec 31, 2017 | -684,000.00 |
| Dec 31, 2017 | -684,000.00 |
| Sep 30, 2017 | -1.44 Mn |
| Sep 30, 2017 | -1.44 Mn |
| Jun 30, 2017 | 8.40 Mn |
| Jun 30, 2017 | 8.40 Mn |
| Mar 31, 2017 | 25.09 Mn |
| Mar 31, 2017 | 25.09 Mn |
| Dec 31, 2016 | -254,000.00 |
| Dec 31, 2016 | -254,000.00 |
| Sep 30, 2016 | 7,987.00 |
| Sep 30, 2016 | 7,987.00 |
| Jun 30, 2016 | 1,834.00 |
| Jun 30, 2016 | 1,834.00 |
| Mar 31, 2016 | 3.67 Mn |
| Mar 31, 2016 | 3.67 Mn |
| Dec 31, 2015 | -5.50 Mn |
| Dec 31, 2015 | -5.50 Mn |
| Sep 30, 2015 | 2.86 Mn |
| Sep 30, 2015 | 2.86 Mn |
| Jun 30, 2015 | -1.14 Mn |
| Jun 30, 2015 | -1.14 Mn |
| Mar 31, 2015 | 194,000.00 |
| Mar 31, 2015 | 194,000.00 |
| Dec 31, 2014 | 20.79 Mn |
| Dec 31, 2014 | 20.79 Mn |
| Sep 30, 2014 | -791,000.00 |
| Sep 30, 2014 | -791,000.00 |
| Jun 30, 2014 | 5.60 Mn |
| Jun 30, 2014 | 5.60 Mn |
| Mar 31, 2014 | 4.90 Mn |
| Mar 31, 2014 | 4.90 Mn |
| Dec 31, 2013 | 2.40 Mn |
| Dec 31, 2013 | 2.40 Mn |
| Sep 30, 2013 | 832,000.00 |
| Sep 30, 2013 | 832,000.00 |
| Jun 30, 2013 | -4.31 Mn |
| Jun 30, 2013 | -4.31 Mn |
| Mar 31, 2013 | 837,000.00 |
| Mar 31, 2013 | 837,000.00 |
| Dec 31, 2012 | -8.53 Mn |
| Dec 31, 2012 | -8.53 Mn |
| Sep 30, 2012 | -15.03 Mn |
| Sep 30, 2012 | -15.03 Mn |
| Jun 30, 2012 | 6.69 Mn |
| Jun 30, 2012 | 6.69 Mn |
| Mar 31, 2012 | -29,000.00 |
| Mar 31, 2012 | -29,000.00 |
| Dec 31, 2011 | -10.20 Mn |
| Dec 31, 2011 | -10.20 Mn |
| Sep 30, 2011 | 1.64 Mn |
| Sep 30, 2011 | 1.64 Mn |
| Jun 30, 2011 | -9.35 Mn |
| Jun 30, 2011 | -9.35 Mn |
| Mar 31, 2011 | 80,000.00 |
| Mar 31, 2011 | 80,000.00 |
| Dec 31, 2010 | 34.74 Mn |
| Dec 31, 2010 | 34.74 Mn |
| Sep 30, 2010 | -41.77 Mn |
| Sep 30, 2010 | -41.77 Mn |
| Jun 30, 2010 | 8.25 Mn |
| Jun 30, 2010 | 8.25 Mn |
| Mar 31, 2010 | -16.75 Mn |
| Mar 31, 2010 | -16.75 Mn |